The role of recombinant insulin-like growth factor I in the treatment of the short child.
about
Profile of mecasermin for the long-term treatment of growth failure in children and adolescents with severe primary IGF-1 deficiencyPhelan-McDermid Syndrome and SHANK3: Implications for Treatment.Cost-effectiveness landscape analysis of treatments addressing xerostomia in patients receiving head and neck radiation therapyElbow loading promotes longitudinal bone growth of the ulna and the humerus.Insulin glargine reduces carotid intimal hyperplasia after balloon catheter injury in Zucker fatty rats possibly by reduction in oxidative stress.IGF-1 restores visual cortex plasticity in adult life by reducing local GABA levelsThe therapeutic potential of insulin-like growth factor-1 in central nervous system disorders.Primum non nocere (first, not to harm) and secundus, opinio vulnero (second, report the harm)A novel rapid analysis using mass spectrometry to evaluate downstream refolding of recombinant human insulin-like growth factor-1 (mecasermin).Recombinant production of mecasermin in E. coli expression systemIGF2-driven PI3 kinase and TGFbeta signaling pathways in chondrogenesis.Controlled release of insulin-like growth factor 1 enhances urethral sphincter function and histological structure in the treatment of female stress urinary incontinence in a rat model.CCAAT-enhancer binding protein (C/EBP) β regulates insulin-like growth factor (IGF) 1 expression in porcine liver during prenatal and postnatal development.
P2860
Q24654465-48698541-F374-4975-803A-38C5EC24D3D6Q30009184-783991D5-C53A-430E-8389-BF6C4433D12FQ33601605-12251B5C-72E5-4E9B-B4F5-7A2DDCAC529EQ33958362-30FFF761-450D-4E31-88A1-9F710AF0B7B1Q35565342-F0296A6C-C96D-47ED-9899-6651BA022AFAQ36031801-C7943064-1A2A-4420-9E23-7A281E8574E7Q36684355-83CF1194-8ACC-4772-874B-F268D3BB8988Q37420804-E2D6E9A5-659D-45E9-BAC0-F950C6C4988AQ38775433-5F832983-8F67-4EBB-BB07-6AB57A0F915EQ42555954-7893E088-BE85-4BBF-8359-892FE5A7D376Q43239899-EA0924C7-F82B-4DEE-AA91-9ED7F96A1730Q47668527-67CEE1E2-3B36-41EA-BD00-7E1EB3F32038Q50611250-5DAA8526-660F-4A61-B562-8FFE7762AA8C
P2860
The role of recombinant insulin-like growth factor I in the treatment of the short child.
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The role of recombinant insulin-like growth factor I in the treatment of the short child.
@ast
The role of recombinant insulin-like growth factor I in the treatment of the short child.
@en
The role of recombinant insulin-like growth factor I in the treatment of the short child.
@nl
type
label
The role of recombinant insulin-like growth factor I in the treatment of the short child.
@ast
The role of recombinant insulin-like growth factor I in the treatment of the short child.
@en
The role of recombinant insulin-like growth factor I in the treatment of the short child.
@nl
prefLabel
The role of recombinant insulin-like growth factor I in the treatment of the short child.
@ast
The role of recombinant insulin-like growth factor I in the treatment of the short child.
@en
The role of recombinant insulin-like growth factor I in the treatment of the short child.
@nl
P1476
The role of recombinant insulin-like growth factor I in the treatment of the short child.
@en
P2093
Arlan L Rosenbloom
P304
P356
10.1097/MOP.0B013E3282094126
P577
2007-08-01T00:00:00Z